A New York Times health reporter explains what clinical trials are, why they are important and how they can help inform us. Credit...Ricardo Tomás Supported by By Nina Agrawal Nina Agrawal is a health ...

Rheumatology clinical trials are adapting to changing patient populations, with implications for recruitment, trial design, and treatment evaluation.

An empirical study reveals that clinical prediction model stability depends not only on sample size but also on algorithm ...

(TOKYO:4263) announced that "SUSMED SourceDataSync®" ("SUSMED SDS"), its proprietary blockchain-based clinical trial system, ...

The clinical trial landscape is continually adapting its focus on patient-centric practices to improve clinical trial participation by reducing patients' burden. Over the past few years, this shift ...

Hello.This is Pharma.In the previous article, 'Can AI Be Used for External Controls and Synthetic Control Arms?', we ...

PRNewswire/ -- ("Resonant"), a global clinical solutions partner serving life sciences organizations across the clinical ...

Scott Piergrossi, president of creative for the healthcare industry naming giant Brand Institute, estimated that acronyms only make up about one-third of the trial names the institute helps create.

Collaboration across provinces, industry, and research institutions is helping Canada rebuild its competitiveness in global ...

IQVIA (NYSE:IQV), a leading global provider of clinical research services, commercial insights and healthcare intelligence to the life sciences and healthcare industries, today at TechIQ 2026 ...